Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
Ocular implant made by a double extrusion process
US9192511B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9192511-B2 |
| Application number | US-201313922482-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 20, 2013 |
| Priority date | Jan 9, 2003 |
| Publication date | Nov 24, 2015 |
| Grant date | Nov 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.
First claim
Opening claim text (preview).
We claim: 1. A bioerodible implant for treating a medical condition of the eye, the bioerodible implant comprising: an active agent homogenously dispersed within a biodegradable polymer matrix, the biodegradable polymer matrix comprising a mixture of a first polymer and a second polymer, the first polymer being different than the second polymer; wherein the bioerodible implant is sized for implantation in an ocular region and the bioerodible implant comprises a double extruded…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9192511B2 cover?
- The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.
- Who is the assignee on this patent?
- Allergan Inc
- What technology area does this patent fall under?
- Primary CPC classification A61F9/0017. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).